Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

8.38
-0.1400-1.64%
Post-market: 8.36-0.0200-0.24%19:59 EDT
Volume:2.66M
Turnover:22.39M
Market Cap:1.36B
PE:3.29
High:8.58
Open:8.50
Low:8.28
Close:8.52
52wk High:11.55
52wk Low:5.01
Shares:162.42M
Float Shares:136.72M
Volume Ratio:0.91
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.54
EPS(LYR):-1.2320
ROE:-898.20%
ROA:14.52%
PB:36.18
PE(LYR):-6.80

Loading ...

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Oct 17

BUZZ-U.S. STOCKS ON THE MOVE-Spyre Therapeutics, Astria, Walmart

Reuters
·
Oct 15

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires Live
·
Oct 15

Novavax Shares up 4.3% After Shah Capital Pushes for Co's Sale

THOMSON REUTERS
·
Oct 14

Shah Capital pushes for Novavax’s sale on underperformance, Reuters says

TIPRANKS
·
Oct 14

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Domino's Pizza, Pattern Group

Reuters
·
Oct 14

BUZZ-Novavax falls as top investor urges sale over poor COVID shot rollout

Reuters
·
Oct 14

BRIEF-Shah Capital Recommends Immediate Formal Strategic Review For Sale Of Novavax

Reuters
·
Oct 14

Shah Capital: Recommends Immediate Formal Strategic Review for Sale of Novavax

THOMSON REUTERS
·
Oct 14

Shah Capital: Currently Owns 7.2% of Novavax

THOMSON REUTERS
·
Oct 14

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 14

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Oct 11

Novavax Inc. Stock Slides 3.5%, Underperforms Peers

Dow Jones
·
Oct 10

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 08

Novavax Inc - Transfer Completion Triggers $25 Mln Payment From Sanofi to Novavax - SEC Filing

THOMSON REUTERS
·
Oct 07

Novavax Inc - Completed Transfer of Marketing Authorization for Its Covid-19 Vaccine, Nuvaxovid(Reg) to Sanofi, in European Union

THOMSON REUTERS
·
Oct 07

Novavax Inc - Anticipates Receipt of Payment in the First Quarter of 2026

THOMSON REUTERS
·
Oct 07

Novavax Completes EU Marketing Authorization Transfer for Nuvaxovid to Sanofi, Receives $25 Million Milestone Payment

Reuters
·
Oct 07

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

THOMSON REUTERS
·
Oct 07